Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, December 28, 2014 12:52:49 PM
bullish
quick trade
long term trend fine
$AGIO recent news/filings
## source: finance.yahoo.com
Fri, 26 Dec 2014 18:21:01 GMT ~ Nasdaq stocks posting largest percentage increases
[AP] - A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.: OvaScience Inc. rose 34.9 percent to $47.16. Tetraphase Pharmaceuticals Inc. rose 14.9 percent to $38.14. Dicerna Pharma rose 14.8 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************
Tue, 23 Dec 2014 19:35:25 GMT ~ Biotech Stocks Sell Off, ETFs Fall Over 5%
read full: http://finance.yahoo.com/news/biotech-stocks-sell-off-etfs-193525958.html
*********************************************************
Tue, 23 Dec 2014 18:44:00 GMT ~ 5 Stocks With Major Insider Buying: Agios Pharmaceuticals and More
read full: http://www.thestreet.com/story/12994553/1/5-stocks-with-major-insider-buying-agios-pharmaceuticals-and-more.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Tue, 23 Dec 2014 16:17:01 GMT ~ Biotech Bull Markets and Billion-Dollar Valuations
read full: http://finance.yahoo.com/tumblr/blog-biotech-bull-markets-and-billion-dollar-valuations-161706408.html
*********************************************************
Sat, 20 Dec 2014 14:10:29 GMT ~ Despite Huge Rally, High-Profile Insiders Still Buying Stocks
read full: http://247wallst.com/investing/2014/12/20/despite-huge-rally-high-profile-insiders-still-buying-stocks/
*********************************************************
$AGIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AGIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AGIO/company-info
Ticker: $AGIO
OTC Market Place: Not Available
CIK code: not found
Company name: Agios Pharmaceuticals, Inc.
Incorporated In:
Business Description:
$AGIO share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AGIO extra dd links
Company name: Agios Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AGIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AGIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AGIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/news - http://finance.yahoo.com/q/h?s=AGIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AGIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AGIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AGIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Agios+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Agios+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Agios+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AGIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AGIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AGIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AGIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AGIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AGIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AGIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AGIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AGIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AGIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AGIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AGIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AGIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AGIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AGIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AGIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AGIO
$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO
Recent AGIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 08:15:29 PM
- Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS) • GlobeNewswire Inc. • 09/11/2024 11:00:00 AM
- Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024 • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:12:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 09:15:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/08/2024 08:08:48 PM
- Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib • GlobeNewswire Inc. • 08/06/2024 09:50:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 01:49:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:03:30 AM
- Agios Reports Business Highlights and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 10:31:00 AM
- Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused • GlobeNewswire Inc. • 08/01/2024 10:30:00 AM
- Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024 • GlobeNewswire Inc. • 07/18/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:22:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:19:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:18:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:15:52 PM
- Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress • GlobeNewswire Inc. • 06/15/2024 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:25:21 PM
- Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET • GlobeNewswire Inc. • 06/06/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/05/2024 11:50:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:14:51 PM
- Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia • GlobeNewswire Inc. • 06/03/2024 10:30:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM